Skip to main content

Table 1 Clinicopathological features of the patients enrolled in this study that underwent six cycles of paclitaxel/carboplatin-based chemotherapy for treatment of EOC

From: Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer

Patient no.

Histology

FIGO stage

Age, y

Tumor grade*

1

Serous

III C

69

High

2

Serous

III C

57

High

3

Serous

III B

41

High

4

Serous

II A

50

High

5

Serous

III C

67

High

6

Serous

III C

64

High

7

Serous

III B

73

High

8

Adenosquamous

II B

51

High

9

Adenosquamous

III C

69

High

10

Serous

III C

55

High

11

Serous

III C

71

High

12

Serous

III C

60

High

13

Serous

III C

53

High

  1. *According to International Federation of Obstetrics and Gynecology (FIGO) criteria.